Pulse oximetry as a screening test for congenital heart defects in newborn infants: A test accuracy study with evaluation of acceptability and cost-effectiveness

Health Technology Assessment

Volumn 16, Issue 2, 2012, Pages

  Ewer, A K ^a,b   Furmston, A T ^a   Middleton, L J ^a   Deeks, J J ^a   Daniels, J P ^a   Pattison, H M ^c   Powell, R ^c   Roberts, T E ^a   Barton, P ^a   Auguste, P ^a   Bhoyar, A ^b   Thangaratinam, S ^a,b   Tonks, A M ^d   Satodia, P ^e   Deshpande, S ^f   Kumararatne, B ^g   Sivakumar, S ^h   Mupanemunda, R ⁱ   Khan, K S ^j  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b BIRMINGHAM CHILDREN S HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^c ASTON UNIVERSITY   (United Kingdom)

^d West Midlands Perinatal Institute   (United Kingdom)

^e UNIVERSITY HOSPITALS COVENTRY AND WARWICKSHIRE NHS TRUST   (United Kingdom)

^f PRINCESS ROYAL HOSPITAL   (United Kingdom)

^g ROYAL WOLVERHAMPTON HOSPITALS NHS TRUST   (United Kingdom)

^h SANDWELL AND WEST BIRMINGHAM HOSPITALS NHS TRUST   (United Kingdom)

ⁱ UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^j QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CAUCASIAN; CHILD SAFETY; CHILDHOOD MORTALITY; CLINICAL EXAMINATION; CONFIDENCE INTERVAL; CONGENITAL HEART DISEASE; COST EFFECTIVENESS ANALYSIS; DATA BASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; ECHOCARDIOGRAPHY; FALSE POSITIVE RESULT; FETUS ECHOGRAPHY; FOLLOW UP; GESTATIONAL AGE; HEALTH CARE COST; HEALTH PERSONNEL ATTITUDE; HOSPITAL DISCHARGE; HUMAN; INFORMATION PROCESSING; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MATERNITY WARD; MEDICAL RESEARCH; MULTICENTER STUDY; NEWBORN; NEWBORN INFECTION; NEWBORN SCREENING; PARENTAL ATTITUDE; PATIENT PARTICIPATION; PREVALENCE; PULSE OXIMETRY; QUESTIONNAIRE; RESPIRATORY TRACT DISEASE; SATISFACTION; SENSITIVITY AND SPECIFICITY; UNITED KINGDOM; ADULT; ANALYSIS OF VARIANCE; COHORT ANALYSIS; CONGENITAL HEART MALFORMATION; COST BENEFIT ANALYSIS; ECONOMICS; EVALUATION STUDY; FEMALE; HOSPITAL DEPARTMENT; MALE; METHODOLOGY; MOTHER; OXIMETRY; PATIENT SATISFACTION; PSYCHOLOGICAL ASPECT; RISK FACTOR; STANDARD; YOUNG ADULT;

ADULT; ANALYSIS OF VARIANCE; ATTITUDE OF HEALTH PERSONNEL; COHORT STUDIES; COST-BENEFIT ANALYSIS; ECHOCARDIOGRAPHY; FEMALE; GREAT BRITAIN; HEART DEFECTS, CONGENITAL; HUMANS; INFANT, NEWBORN; MALE; MOTHERS; NEONATAL SCREENING; OBSTETRICS AND GYNECOLOGY DEPARTMENT, HOSPITAL; OXIMETRY; PATIENT SATISFACTION; QUESTIONNAIRES; RISK FACTORS; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84856773952     PISSN: 13665278     EISSN: 20464924     Source Type: Journal    
DOI: 10.3310/hta16020     Document Type: Article

References (101)

1. Lloyd-Jones D, Adams R, Carnethon M, De Simone G, Ferguson TB, Flegal K, et al. Heart disease and stroke statistics 2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009;119:e21-181.
2. Wren C, Reinhardt Z, Khawaja K. Twenty-year trends in diagnosis of life-threatening neonatal cardiovascuar malformations. Arch Dis Child Fetal Neonatal Ed 2008;93:F33-5.
3. Botto LD, Correa A, Erickson D. Racial and temporal variations in the prevalence of heart defects. Pediatrics 2001;107:e32.
4. Death Registrations in England and Wales, 2002: causes. Health Stat Q 2003;18:57-64.
5. Boneva RS, Botton LD, Moore CA, Yang Q, Correa A, Erickson D. Mortality associated with congenital heart defects in the United States: trends and racial disparaties 1979-1997. Circulation 2001;103:2376-81.
6. Knowles R, Griebsch I, Dezateux C, Brown J, Bull C, Wren C. Newborn screening for congenital heart defects: a systematic review and cost-effectiveness analysis. Health Technol Assess 2005;9(44).
7. Hoffman JIE, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol 2002;39:1890-900.
8. Wren C, Richmond S, Donaldson L. Temporal variability in birth prevalence of cardiovascular malformations. Heart 2000;83:414-19.
9. Tikanoja T. Effect of technical development on the apparent incidence of congenital heart disease. Pediatric Cardiol 1995;16:100-1.
10. Mahle WT, Newburger JW, Matherne GP, Smith FC, Hoke TR, Koppel R, et al. Role of pulse oximetry in examining newborns for congenital heart disease: a scientific statement from the AHA and AAP. Pediatrics 2009;124:823-36.
11. Mitchell SC, Korones SB, Berendes HW. Congenital heart disease in 56,109 births incidence and natural history. Circulation 1971;43:323-32.
12. Barrington KJ. Neonatal screening for life threatening congenital heart disease. BMJ 2009;338:117-18.
13. Richmond S, Reay G, Abu Harb M. Routine pulse oximetry in the asymptomatic newborn. Arch Dis Child Fetal Neonatal Ed 2002;87:F83-8.
14. Samanek M, Goetzova J, Benesova D. Causes of death in neonates born with a heart malformation. Int J Cardiol 1986;11:63-74.
15. Brown KL, Ridout DA, Hoskote A, Verhulst L, Ricci M, Bull C. Delayed diagnosis of congenital heart disease worsens preoperative condition and outcome of surgery in neonates. Heart 2006;92:1298-302.
16. Brown JW, Park HJ, Turrentine MW. Arterial switch operation: factors impacting survival in the current era. Ann Thorac Surg 2001;71:1978-84.
17. Franklin O, Burch M, Manning N, Sleeman K, Gould S, Archer N. Prenatal diagnosis of coarctation of the aorta improves survival and reduces morbidity. Heart 2002;87:67-9.
18. Tworetsky W, McElhinney DB, Reddy VM, Brook MM, Hanley FL, Silverman NH. Improved surgical outcome after fetal diagnosis of hypoplastic left heart syndrome. Circulation 2001;103:1269-73.
19. Abu-Harb M, Hey E, Wren C. Death in infancy from unrecognised congenital heart disease. Arch Dis Child 1994;71:3-7.
20. Mellander M, Sunnegardh J. Failure to diagnose critical heart malformations in newborns before discharge: an increasing problem? Acta Paediatrica 2006;95:407-13.
21. Abu-Harb M, Wyllie J, Hey E, Richmond S, Wren C. Presentations of obstructive left heart malformations in infancy. Arch Dis Child 1994;71:F179-83.
22. Kuehl KS, Loffredo CA, Ferencz C. Failure to diagnose congenital heart disease in infancy. Pediatrics 1999;103:743-7.
23. Chang R-KR, Gurvitz M, Rodriguez S. Missed diagnosis of critical congenital heart disease. Arch Pediatr Adolesc Med 2008;162:969-74.
24. Hall DMB, Elliman D. Health for all children. 4th edn. Oxford: Oxford University Press; 2003.
25. Hall DMB. The role of the routine neonatal examination. BMJ 1999;318:619-20.
26. Wren C, Richmond S, Donaldson L. Presentation of congenital heart disease in infancy: implications for routine examination. Arch Dis Child Fetal Neonatal Ed 1999;80:F49-53.
27. O'Donnell CPF, Kamlin COF, Davis PG, Carlin JB, Morley CJ. Clinical assessment of infant colour at delivery. Arch Dis Child Fetal Neonatal Ed 2007;92:F465-7.
28. Ainsworth SB, Wyllie JP, Wren C. Prevalence and clinical significance of cardiac murmurs in neonates. Arch Dis Child Fetal Neonatal Ed 1999;80:F43-5.
29. Marbella AM, Chetty VK, Layde PM. Neonatal hospital lengths of stay, readmissions, and charges. Pediatrics 1998;101:32-6.
30. Kotagal UR, Atherton HD, Eshett R, Schoettker PJ, Perlstein PH. Safety of early discharge for Medicaid newborns. JAMA 1999;282:1150-6.
31. Wen SW, Liu S, Marcoux S, Fowler D. Trends and variations in length of hospital stay for childbirth in Canada. Can Med Assoc J 1998;158:875-80.
32. Odlind V, Haglund B, Pakkanen M, Otterblad Olausson P. Deliveries, mothers and newborn infants in Sweden, 1973-2000. Trends in obstetrics as reported to the Swedish Medical Birth Register. Acta Obstet Gynecol Scand 2003;82:516-28.
33. Bull C. Current and potential impact of fetal diagnosis on prevalence and spectrum of serious congenital heart disease at term in the UK. Lancet 1999;354:1242-7.
34. Allan LD, Crawford DC, Chita SK, Tynan MJ. Prenatal screening for congenital heart disease. BMJ 1986;292:1717-19.
35. Sharland G. Fetal cardiac screening; why bother? Arch Dis Child 2009;95:F64-8.
36. UK National Screening Committee. Antenatal ultrasound screening ultrasound survey of England 2002. London: UK National Screening Committee; April 2005.
37. Royal College of Obstetrics and Gynaecology (RCOG). Ultrasound screening: supplement to ultrasound screening for fetal abnormalities. London: RCOG; 2000.
38. National Institute for Health and Clinical Excellence (NICE). Antenatal care: routine care for the healthy pregnant woman. Clinical Guideline, March 2008. London: NICE; 2008.
39. Khoshnood B, De Vigan C, Vodovar V, Goujard J, Lhomme A, Bonnet D, et al. Trends in prenatal diagnosis, pregnancy termination, and perinatal mortality of newborns with congenital heart disease in France, 1983-2000: a population-based evaluation. Pediatrics 2005;115:95-101.
40. Bonnet D, Cotri A, Butera G, Fermont L, Le Bidois J, Kachaner J, et al. Detection of transposition of the great arteries in fetuses reduces neonatal morbidity and mortality. Circulation 1999;99:916-18.
41. Verheijen PM, Lisowski LA, Stoutenbeek P, Hitchcock JF, Brenner JI, Copel JA, et al. Prenatal diagnosis of congenital heart disease affects preoperative acidosis in the newborn patient. J Thorac Cardiovasc Surg 2001;121:798-803.
42. Carvalho JS, Mavrides E, Shinebourne EA. Improving the effectiveness of routine prenatal screening for major congenital heart defects. Heart 2002;88:387-91.
43. Tegnander E, Williams W, Johansen OJ, Blaas H-GK, Eik-Nes SH. Prenatal detection of heart defects in a non-selected population of 30 149 fetuses: detection rates and outcomes. Ultrasound Obstet Gynecol 2006;27:252-65.
44. Chew C, Halliday JL, Riley MM, Penny DJ. Population-based study of antenatal detection of congenital heart disease by ultrasound examination. Ultrasound Obstet Gynecol 2007;29:619-24.
45. Garne E, Stoll C, Clementi M, and the Euroscan Group. Evaluation of prenatal diagnosis if congenital heart doseases by ultrasound: experience from 20 European registries. Ultrasound Obstet Gynecol 2001;17:386-91.
46. Westin M, Saltvedt S, Bergman G, Kublickas M, Almstrom H, Grunewald C, et al. Routine ultrasound examination at 12 or 18 gestational weeks for prenatal detection of major congenital heart malformations? A randomised controlled trial comprising 36 299 fetuses. BJOG 2006;113:675-82.
47. Jaeggi ET, Sholler GF, Jones ODH, Cooper SG. Comparative analysis of pattern, management and outcome of pre- versus postnatally diagnosed major congenital heart disease: a population-based study. Ultrasound Obstet Gynecol 2001;17:380-5.
48. Bricker L, Garda J, Henderson J, Mugford M, Neilson J, Roberts T, et al. Ultrasound screening pregnancy: a systematic review of the clincial effectiveness, cost effectiveness and women's views. Health Technol Assess 2000;4(16).
49. Acharya G, Sitras V, Maltau JM, Dahl LB, Kaaresen PI, Hanssen TA, et al. Major congenital heart disease in Northern Norway: shortcomings of pre- and postnatal diagnosis. Acta Obstet Gynecol Scand 2004;83:1124-9.
50. Kirwan D, and the NHS Fetal Anomaly Screening Programme (NHS FASP). NHS Fetal Anomaly Screening Programme. 18+0 to 20+6 weeks fetal anomaly scan standards and Guidance for England. NHS Fetal Anomaly Screening Programme; January 2010.
51. Rasiah SV, Publicover M, Ewer AK, Khan KS, Kilby MD, Zamora J. A systematic review of the accuracy of first-trimester ultrasound examination for detecting major congenital heart disease. Ultrasound Obstet Gynecol 2006;28:110-16.
52. Sharland G. Changing impact of fetal diagnosis of congenital heart disease. Arch Dis Child Fetal Neonatal Ed 1997;77:F1-3.
53. Sharland G. Fetal cardiac screening: why bother? Arch Dis Child Fetal Neonatal Ed 2010;95:F64-8.
54. Randall P, Brealey S, Hahn S, Khan KS, Parsons JM. Accuracy of fetal echocardiography in the routine detection of congenital heart disease among unselected and low risk populations: a systematic review. BJOG 2005;112:24-30.
55. Sharland G. Routine fetal cardiac screening: what are we doing and what should we do? Prenat Diagn 2004;24:1123-9.
56. Mahle WT. Physical examination and pulse oximetry in newborn infants: out with the old, in with the new? J Pediatrics 2008;152:747-8.
57. Valmari P. Should pulse oximetry be used to screen for congenital heart disease? Arch Dis Child Fetal Neonatal Ed 2007;92:F219-24.
58. Poets CF, Southall DP. Noninvasive monitoring of oxygenation in infants and children: practical considerations and areas of concern. Pediatrics 1994;93:737-46.
59. Seelbach-Gobel B, Heupel M, Kuhnert M, Butterwegge M. The prediction of fetal acidosis by means of intrapartum fetal pulse oximetry. Am J Obstet Gynecol 1999;180:73-81.
60. Toth B, Becker A, Seelbach-Gobel B. Oxygen saturation in healthy newborn infants immediately after birth measured by pulse oximetry. Arch Gynecol Obstet 2002;266:105-7.
61. Levesque BM, Pollack P, Griffin BE, Nielsen HC. Pulse oximetry: what's normal in the newborn nursery? Pediatr Pulmonol 2000;30:406-12.
62. Bakr AF, Habib HS. Combining pulse oximetry and clinical examination in screening for congenital heart disease. Pediatric Cardiol 2005;26:832-5.
63. Hoke TR, Donohue PK, Bawa PK, Mitchell RD, Pathak A, Rowe PC, et al. Oxygen saturation as a screening test for critical congenital heart disease: a preliminary study. Pediatric Cardiol 2002;23:403-9.
64. Koppel RI, Druschel C, Carter T, Goldberg B, Mehta P, Talwar R, et al. Effectiveness of pulse oximetry screening for congenital heart disease in asymptomatic newborns. Pediatrics 2003;111:451-5.
65. Reich J, Miller S, Brogdon B, Casatelli J, Gompf T, Huhta J, et al. The use of pulse oximetry to detect congenital heart disease. J Pediatrics 2003;142:268-72.
66. de Wahl Granelli A, Mellander M, Sunnegardh J, Sandberg K, Ostman-Smith I. Screening for duct-dependant congenital heart disease with pulse oximetry: a critical evaluation of strategies to maximize sensitivity. Acta Paediatr 2005;94:1590-6.
67. Rosati E, Chitano G, Dipaola L, De Felice C, Latini G. Indications and limitations for a neonatal pulse oximetry screening of critical congenital heart disease. J Perinat Med 2005;33:455-7.
68. Sendelbach DM, Jackson GL, Lai SS, Fixler DE, Stehel EK, Engle WD. Pulse oximetry screening at 4 hours of age to detect critical congenital heart defects. Pediatrics 2008;122:e815-20.
69. Meberg A, Brugmann-Pieper S, Reidar D, Jr, Eskedal L, Fagerli I, Farstad T, et al. First day of life pulse oximetry screening to detect congenital heart defects. J Pediatr 2008;152:761-5.
70. de Wahl Granelli A, Wennergren M, Sandberg K, Mellander M, Bejlum C, Inganas L, et al. Impact of pulse oximetry screening on detection of duct dependent congenital heart disease: a swedish prospective screening study in 39 821 newborns. BMJ 2009;338:A3037.
71. Arlettaz R, Bauschatz A, Mankhoff M, Essers B, Bauersfeld U. The contribution of pulse oximetry to the early detection of congenital heart disease in newborns. Eur J Pediatrics 2006;165:94-8.
72. Thangaratinam S, Daniels JP, Ewer AK, Zamora J, Khan KS. The accuracy of pulse oximetry in screening for congenital heart disease in asymptomatic newborns: a systematic review. Arch Dis Child 2006;58:137-41.
73. Green J, Statham H. Testing for fetal abnormality in routine antenatal care. Midwifery 1993;9:124-35.
74. Pollitt RJ, Green A, McCabe CJ, Booth A, Cooper NJ, Leonard JV. Neonatal screening for inborn errors of metabolism: cost, yield and outcome. Health Technol Assess 1997;1(7).
75. McCrindle BW, Shaffer KM, Kan JS, Zahka KG, Rowe SA, Kidd L. An evaluation of parental concerns and misperceptions about heart murmurs. Clin Pediatr 1995;34:25-31.
76. Fyro K, Bodegard G. Four-year follow-up of psychological reactions to false positive screening tests for congenital hypothyroidism. Acta Paediatr Scand 1987;76:107-14.
77. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. BMJ 2003;326:41-4.
78. Knottnerus JA, Muris JW. Assessment of the accuracy of diagnostic tests: the cross-sectional study. J Clin Epidemiol 2003;56:1118-28.
79. Knottnerus JA, Muris JW. Assessment of the accuracy of diagnostic tests: the cross sectional study. In Knottnerus JA, editor. The evidence base of clinical diagnostics. London: BMJ Books; 2002. pp. 39-59.
80. Daniels JP, Gray J, Pattison H, Roberts T, Edwards E, Milner P, et al. Rapid testing for group B streptococcus during labour: a test accuracy study with evaluation of acceptability and cost-effectiveness. Health Technology Assess 2009;13(42).
81. Clopper C, Pearson ES. The use of confidence or fiducial limits illustrated in the case of the binomial. Biometrika 1934;26:404-13.
82. Baillie C, Smith J, Hewison J, Mason G. Ultrasound screening for chromosomal abnormality: women's reactions to false positive results. Br J Health Psychol 2000;5:377-94.
83. Rowe RE, Garcia J, Davidson LL. Social and ethnic inequalities in the offer and uptake of prenatal screening and diagnosis in the UK: a systematic review. Publ Health 2004;118:177-89.
84. Ware JEJ, Snyder MK, Wright WR. Defining and measuring patient satisfaction with medical care. Eval Program Plann 1983;6:247-63.
85. Sitzia J, Wood N. Patient satisfaction: a review of issues and concepts. Soc Sci Med 1997;45:1829-43.
86. Spielberger C. Manual for the state trait anxiety inventory STAI (form Y). Palo Alto, CA: Consulting Psychologists Press; 1983.
87. Marteau TM, Bekker H. The development of a six-item short-form of the state scale of the Spielberger State-Trait Anxiety Inventory (STAI). Br J Clin Psychol 1992;31:301-6.
88. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983;67:361-70.
89. Michie S, Bobrow M, Marteau TM. Predictive genetic testing in children and adults: a study of emotional impact. J Med Genet 2001;38:519-26.
90. Broadbent E, Petrie KJ, Main J, Weinman J. The brief illness perception questionnaire. J Psychosom Res 2006;60:631-7.
91. Scheier MF, Carver CS. Optimism, coping and health: assessment and implications of generalized outcome expectancies. Health Psychol 1985;4:219-47.
92. Johnston M, Wright S, Weinman J. Measures in health psychology: a user's portfolio. Windsor: NFER-NELSON Publishing Company; 1995.
93. Tabachnick BG, Fidell LS. Using multivariate statistics. Boston, MA: Pearson; Allyn and Bacon; 2007.
94. Ritchie R, Spencer L. Qualitative data analysis for applied policy research. In Bryman A, Burgess RG, editors. Analyzing qualitative data. London: Routledge; 1994.
95. Hunink M, Glasziou P. Decision making in health and medicine, integrating evidence and values. Cambridge: Cambridge University Press; 2001.
96. Curtis L. Unit costs of health and social care. London: Personal Social Services Research Unit; 2009.
97. Drummond MF, O'Brien B, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programmes. 3rd edn. Oxford: Oxford Univesity Press; 2005.
98. Briggs A, Claxton K, Sculpher M. Decision modelling for health economic evaluation. Oxford: Oxford University Press; 2006.
99. Torrance GW. Measurement of health state utilities for economic appraisal. J Health Econ 1986;5:1-30.
100. Thompson SG, Barber JA. How should cost data in pragmatic randomised trials be analysed? BMJ 2000;320:29.
101. Alonzo TA, Pepe MS, Moskowitz CS. Sample size calculations for comparative studies of medical tests for detecting presence of disease. Stat Med 2002;21:835-52.